Newly developed oral formulas represent a compelling and untapped area of investigation and clinical potential
For example, oral intake of 500 mg/day novel Actbiome formulation, (curcumin and asafetida complex was incorporated into turmeric fiber) for 8 weeks showed a reduction in IL-10 and gastrointestinal symptom rating scale (GSRS) score and increased fecal bifidobacteria, fecal lactobacilli, and ideal stool form and frequency without any side effects in healthy subjects
PT-141, or bremelanotide, holds FDA approval for hypoactive sexual desire disorder in women but circulates widely in the grey market at uncontrolled doses for far broader uses
Serum copper, ceruloplasmin, and liver enzymes are ordinary, inexpensive assays
Experimental and clinical evidence of the effectiveness of riboflavin on migraines
Disease Markers 26 (1): 3539